<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bahi, Amine</dc:creator>
  <dc:creator>Dreyer, Jean-Luc</dc:creator>
  <dc:date>2018-12-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Generalized anxiety and major depression disorders (MDD) are severe debilitating  mood disorders whose etiology are not fully understood, but growing evidence  indicates that microRNAs (miRNAs) might play a key role in their  neuropathophysiological mechanisms. In the current study, we investigate the role of  Lethal-7 (let-7d) miRNA, and its direct target dopamine D3 receptor (D3R) gain-of- function, in the hippocampus, in preclinical models of anxiety and depression in mice.  For this purpose, we have constructed a lentiviral vector carrying let-7d miRNA and its  anxiolytic effect was investigated by employing the open-field (OF) and the elevated  plus maze (EPM) tests. The anti-depressant activity was evaluated using the tail  suspension and the forced-swim tests (TST &amp; FST). Our results show that let-7d  overexpression significantly improved the measures of anxiety in the OF and EPM  tests. In addition, let-7d increased the mobility time in the TST and FST. Interestingly,  gene expression interaction analysis shows that the D3R mRNA negatively correlates  with let-7d expression. In a different set of experiments, we used a tetracycline- inducible (tet-off) lentiviral vector to overexpress D3R to assess its gain-of-function in  the hippocampus on anxiety- and depression-like behaviors. In line, we found that in  the absence of doxycycline, D3R produced a significant anxiogenic and depressant- like response. Most importantly, these effects were abrogated when mice were fed  doxycycline in drinking water. Our results provide the first evidence for an anxiolytic  and anti-depressant-like action of let-7d through a potential D3R target-mediated  mechanism which might open new avenues for anxiolytic and anti-depressant  therapies.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/307245</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307245/files/dre_lml.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307245/files/dre_lml_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.euroneuro.2018.09.004</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>European Neuropsychopharmacology. - 2018, vol. 28, no. 12, p. 1394–1404</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Lentiviral-mediated let-7d microRNA overexpression induced anxiolytic- and anti-depressant-like behaviors and impaired dopamine D3 receptor expression</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
